The Charles Schwab Corporation (NYSE: SCHW) reported third quarter 2020 earnings results today.
Net revenues fell 10% year-over-year to $2.4 billion.
GAAP net income dropped 27% to $698 million while EPS decreased 31% to $0.48. Adjusted net income declined 22% to $749 million while EPS fell 27% to $0.51.
Last week, Charles Schwab completed the acquisition of TD Ameritrade, creating a company with approx. $6 trillion in client assets across 28 million brokerage accounts.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key